COME HOME Treatment Pathways

Evidence Based, Physician Driven, Open Source

The COME HOME treatment pathways are developed and maintained by committees of community and academic oncologists. They are a freely available open source tool. New pathway committees meet twice monthly during pathway construction, and then quarterly to update the pathways and keep them current.

Click Cancer Type, then use additional navigation above footer or in left margin for Stage Specific Pathways.
Cancer Type Stage Updated
Breast Cancer DCIS
Stage I-III
Recurrent or Stage IV: ER or PR pos
Recurrent or Stage IV ER/PR neg or endocrine refractory
Colon Cancer Stage II
Stage III
Stage IV PS 0-2
Stage IV PS 3-4
2017 . 07 . 28
Hodgkin Lymphoma Stage IA or IIA Favorable
Stage I-II Unfavorable
Stage III-IV
Refractory Disease
Melanoma Stage 0-IA
Resectable Stage IB or II
Unresectable Stage III-IV Good PS (0-2)
Unresectable Stage III-IV Poor PS (3-4)
Non-Small Cell Lung Cancer (NSCLC) Stage IA
Stage IB, IIA, IIB
Stage IIIA
Stage IIIB
Metastatic Dis 1st line Rx Non-Squamous
Metastatic Dis 1st line Rx Squamous
Metastatic Dis 2nd line Rx
 2017 . 08 . 18
Pancreatic Cancer Neoadjuvant
Locally Advanced
Metastatic or Recurrent
 2017 . 09 . 15
Thyroid Cancer Metastatic Follicular, Hurthle Cell, Papillary